Adverse drug reactions (ADRs) are rare when lidocaine is used as a local anesthetic and is administered correctly. Most ADRs associated with lidocaine for anesthesia relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, and allergic reactions only rarely occur.[28] Systemic exposure to excessive quantities of lidocaine mainly result in central nervous system (CNS) and cardiovascular effects - CNS effects usually occur at lower blood plasma concentrations and additional cardiovascular effects present at higher concentrations, though cardiovascular collapse may also occur with low concentrations.

Lidocaine chemical raw powder COA:

ITEMS	SPECIFICATIONS	RESULTS
Appearance	White crystalline powder	Pass
Purity	99.00%-101.00%	99.52%
Identification	Chloridate	Positive
	Test A	Positive
Melting point	74-79 degree	76-78 degree
Appearance of solution	Clear and colourless	Pass
Water	5.5-7.0%	6.7%
Acidity PH	4.0-5.5	5.2
Sulphated ash	0.10% max	0.08%
Heavy metals	5ppm max	Pass
2, 6-Dimethylaniline	100ppm max	Pass

Lidocaine is a local anesthetic, also called Xylocaine, in recent years has been replaced by procaine, widely used in cosmetic surgery in local anesthesia, through the sodium channel inhibition of nerve cell membranes to blockade the nerve excitability and conduction. Its fat solubility and protein binding rate were higher than procaine, with strong ability to penetrate cells, fast acting, long action time and 4 times the effect of procaine.

Absolute contraindications for the use of lidocaine include:

Heart block, second or third degree (without pacemaker)
Severe sinoatrial block (without pacemaker)
Serious adverse drug reaction to lidocaine or amide local anesthetics
Hypersensitivity to corn and corn-related products (corn-derived dextrose is used in the mixed injections)
Concurrent treatment with quinidine, flecainide, disopyramide, procainamide (class I antiarrhythmic agents)
Prior use of amiodarone hydrochloride
Adams-Stokes syndrome
Wolff-Parkinson-White syndrome
Lidocaine viscous is not recommended by the FDA to treat teething pain in children and infants.

Packing: 
  1. Inner double plastic bags----25kg/Fiber drum (35*35*45cm, GW: 28kg, NW: 25kg);

  2. Inner double plastic bags----5kg/Aluminum foil bag (GW: 6.5kg, NW: 5kg).

  3. Inner double plastic bags----1kg/Aluminum foil bag (GW: 1.5kg, NW: 1kg).

Delivery:  

  1. Stock products are normally shipping within 3 working days. 

  2. For rush delivery, please contact our sales team for particular arrangement.

  1. We ship goods via DHL, Fedex, UPS, TNT, China post, NL Post and other couriers, weight from 10g to 1000kg or even bulker.

  2. Shipping details & shipping documents will be provided and sent by email.

  3. We keep tracking the shippment until clients well received.

  4. After years export shipping experience, with professional and experienced cooperated forwarders, we ensure that goods can be delivered in multiple ways safetly and efficiently.

Company Information:

Mulei (Wuhan) New Material Technology Co. Ltd is a scientific and technological  company integrating product research and development, manufacturing of chemical intermediates, specialized in organic intermediates, pharmaceutical intermediates, chemical solvents and agrochemical products. We produce and provide fluffy powder,Alpha Bromovalerophenone, Valerophenone, Watermelon ketone and cocoylchloride, etc.

Since 2016, in response to the government guidance, we have been accelerating industrial restructure, enlarging the production capacity gradually. At present, we have over 600 employees, 29 technician; with 11 masters and 4 doctors. With all staffs' effort, Mulei is growing rapidly, products are exported to overseas countries, including Southeast Asia, Europe, North America and South America, well received by customers.